TLX

Telix Pharmaceuticals Limited

HealthcareBiotechnologyAUUSDPeers →Country macro →

$10.09

LiveJun 18, 2026

Market cap

$3.42B

52w range

6.28 – 16.98

P / E

—

EPS

—

Volume

90.46K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Telix Pharmaceuticals Limited’s valuation

○

Sell-side estimates and price targets skew heavily to US large-caps. We don't have consensus data for this issuer yet.